Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.64 SEK | +6.61% | -13.78% | +215.73% |
07/05 | Transcript : Ascelia Pharma AB - Special Call | |
02/05 | Ascelia Pharma AB Successfully Meets Primary Endpoint with Strong Headline Results in Orvigance Phase 3 Study | CI |
- Stock Market
- Equities
- ACE Stock
- News Ascelia Pharma AB
- Transcripts